Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation-Reference-Cited by-同舟云学术

Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation

Published:2011-03-01 Issue:2 Volume:36 Page:208-216
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:

Author:

Miura M.,Niioka T.,Kagaya H.,Saito M.,Hayakari M.,Habuchi T.,Satoh S.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.2010.01163.x/fullpdf

Reference44 articles.

1. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clinical Pharmacokinetics,2004

2. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus;Hesselink;Clinical Pharmacology and Therapeutics,2003

3. Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients;Roy;Pharmacogenetics and Genomics,2006

4. The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?;Hesselink;Pharmacogenomics,2005

5. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells;Nagaya;The Journal of Pharmacology and Experimental Therapeutics,1990

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction;Chemico-Biological Interactions;2024-03

2. Three Layers of Personalized Medicine in the Use of Sirolimus and Its Derivatives for the Treatment of Cancer;Journal of Personalized Medicine;2023-04-27

3. The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients;Journal of Clinical Medicine;2020-01-18

4. CYP3A5 gene polymorphisms and their impact on dosage and trough concentration of tacrolimus among kidney transplant patients: a systematic review and meta-analysis;The Pharmacogenomics Journal;2020-01-06

5. Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant;Therapeutic Drug Monitoring;2016-08